In cancer and precancerous lesions, p16 is considered a tumor suppressor gene and pushes cells to enter senescence, an irreversible cell-cycle arrest and loss of p16 is one of the most frequent events in human tumors allowing precancerous lesions to bypass senescence [49–50]. The gene discussed is CDKN2A; the disease is neoplasm.